Maurizio Inghilleri | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study	MUSCLE & NERVE	2021
Progressione della disfagia orofaringea nella sclerosi laterale amiotrofica: studio retrospettivo longitudinale	Congresso SIAF 2021	2021
Isolated Bilateral Tapia’s syndrome after several oro-tracheal intubations: anatomical and pathophysiological considerations	FUNCTIONAL NEUROLOGY	2020
Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY	2020
Natural killer cells modulate motor neuron-immune cell cross talk in models of amyotrophic lateral sclerosis	NATURE COMMUNICATIONS	2020
Creatine kinase and progression rate in amyotrophic lateral sclerosis	CELLS	2020
Minimal Symptom Expression' in Patients With Acetylcholine Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis Treated With Eculizumab	JOURNAL OF NEUROLOGY	2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY	2020
Nerve high resolution ultrasonography in Tangier disease	MUSCLE & NERVE	2019
Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study	SCIENTIFIC REPORTS	2019
Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment.	CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS	2019
Italian recommendations for the diagnosis and treatment of myasthenia gravis	NEUROLOGICAL SCIENCES	2019
Pnkp deficiency mimicking a benign hereditary chorea. the misleading presentation of a neurodegenerative disorder	PARKINSONISM & RELATED DISORDERS	2019
HETERONYMOUS H REFLEX IN TEMPORAL MUSCLE AS SIGN OF HYPEREXCITABILITY IN ALS PATIENTS	CLINICAL NEUROPHYSIOLOGY	2019
A case of motor neuron involvement in Gaucher disease	MOLECULAR GENETICS AND METABOLISM REPORTS	2019
Eculizumab improves fatigue in refractory generalized myasthenia gravis	QUALITY OF LIFE RESEARCH	2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis	MUSCLE & NERVE	2019
Malattia del motoneurone	La neurologia della Sapienza	2019
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)	QUALITY OF LIFE RESEARCH	2019
Letter to the editor: autoimmune pathogenic mechanisms in Huntington’s disease	AUTOIMMUNITY REVIEWS	2018

Gruppi di ricerca - Responsabile

Gruppo di ricerca sulla sclerosi laterale amiotrofica

Gruppo di ricerca sull'amiloidosi sistemica da transtiretina